Analystreport

Mirati Therapeutics Inc (NASDAQ: MRTX) is now covered by analysts at Piper Jaffray Companies. They set an "overweight" rating on the stock.

Mirati Therapeutics, Inc.  (MRTX) 
Last mirati therapeutics, inc. earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mirati.com/node/5806